Hope Bancorp, Inc. logo HOPE - Hope Bancorp, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 1
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.50 DETAILS
HIGH: $14.50
LOW: $14.50
MEDIAN: $14.50
CONSENSUS: $14.50
UPSIDE: 17.12%

Stock News

AGNICO EAGLE APPROVES HOPE BAY INVESTMENT DECISION; STRONG ECONOMIC RETURNS WITH EXPECTED ANNUAL GOLD PRODUCTION OF OVER 400,000 OUNCES

AGNICO EAGLE APPROVES HOPE BAY INVESTMENT DECISION; STRONG ECONOMIC RETURNS WITH EXPECTED ANNUAL GOLD PRODUCTION OF OVER 400,000 OUNCES

Stock Symbol: AEM (NYSE and TSX) (All amounts expressed in U.S. dollars unless otherwise noted) TORONTO, May 19, 2026 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) ("Agnico Eagle" or the "Company") is pleased to report a positive investment decision for its Hope Bay project, located in Nunavut, Canada. Following significant exploration success in recent years, the Company has completed a preliminary economic assessment (the "2026 Study") which contemplates an underground mining operation supported by a 6,000 tonnes per day ("tpd") processing facility with estimated annual gold production of between 400,000 and 435,000 ounces.

May 19, 2026 02:00 AM prnewswire.com
Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per common share. The dividend is payable on or about May 22, 2026, to all stockholders of record as of the close of business on May 8, 2026. About Hope Bancorp, Inc. Hope Bancorp, Inc. (NASDAQ: HOPE) is the holding company for Bank of Hope, with $18.66 billion in total assets as of March 31, 2026. Following the addition of Terri.

Apr 28, 2026 03:30 AM businesswire.com
Hope Bancorp Reports Financial Results for the First Quarter Ended March 31, 2026

Hope Bancorp Reports Financial Results for the First Quarter Ended March 31, 2026

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company” or “Hope”) (NASDAQ: HOPE), the holding company of Bank of Hope (the “Bank”), today reported unaudited financial results for its first quarter ended March 31, 2026. For the three months ended March 31, 2026, the Company recorded net income of $29.5 million, or $0.23 per diluted common share, up 40% from net income of $21.1 million, or $0.17 per diluted common share, for the three months ended March 31, 2025, and down 14% from net in.

Apr 28, 2026 03:30 AM businesswire.com
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

GOTHENBURG, SE / ACCESS Newswire / April 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, the results from the HOPE-at-Heart clinical trial (NCT06485596) were presented at the ISHLT Annual Meeting in Toronto. This prospective, multicenter trial, is the first to evaluate direct procurement of donor hearts after circulatory death (DCD) followed by preservation using HOPE with the XVIVO Heart Assist Transport.

Apr 22, 2026 12:10 PM accessnewswire.com
Hope Bancorp to Report Financial Results for the First Quarter Ended March 31, 2026, on Tuesday, April 28, 2026

Hope Bancorp to Report Financial Results for the First Quarter Ended March 31, 2026, on Tuesday, April 28, 2026

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (“the Company”) (NASDAQ: HOPE) today announced that the Company will report financial results for its first quarter ended March 31, 2026, before the markets open on Tuesday, April 28, 2026. A conference call to discuss financial results for the first quarter ended March 31, 2026, will be held on Tuesday, April 28, 2026, at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. A presentation deck to accompany the earnings call will be available on Hop.

Apr 14, 2026 03:30 AM businesswire.com
Bank of Hope to Acquire the Commercial Banking Unit of SMBC MANUBANK in Accretive, All-Cash Transaction

Bank of Hope to Acquire the Commercial Banking Unit of SMBC MANUBANK in Accretive, All-Cash Transaction

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) today announced that Bank of Hope, its bank subsidiary, has entered into a definitive agreement under which Bank of Hope will acquire the Commercial Banking Unit (“CBU”) of SMBC MANUBANK, a wholly owned subsidiary of SMBC Americas Holdings, Inc. and Sumitomo Mitsui Banking Corporation (“SMBC”). In addition, Bank of Hope and SMBC intend to enter into a collaboration and partnership agreement to provide commercial and consumer bankin.

Mar 31, 2026 12:30 PM businesswire.com
Capricor: Moving To 'Buy' Rating As New PDUFA Date Is Set For Deramiocel

Capricor: Moving To 'Buy' Rating As New PDUFA Date Is Set For Deramiocel

Capricor Therapeutics is upgraded from 'Hold' to 'Buy' following FDA acceptance of the HOPE-3 clinical study report for Deramiocel in DMD cardiomyopathy. The FDA lifted the Complete Response Letter and set a PDUFA date of August 22, 2026, without requiring new studies, increasing regulatory clarity. Phase 3 HOPE-3 data showed Deramiocel slowed disease progression by 54% [PUL] and 91% [LVEF], with additional functional and fibrosis benefits.

Mar 13, 2026 12:11 PM seekingalpha.com
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

SAN DIEGO, March 12, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced additional analyses and new functional outcomes data from the Phase 3 HOPE-3 clinical trial of Deramiocel in Duchenne muscular dystrophy (DMD), which were presented yesterday at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference in Orlando, Florida.

Mar 12, 2026 05:00 AM globenewswire.com
Critical Review: Glacier Bancorp (NYSE:GBCI) versus Hope Bancorp (NASDAQ:HOPE)

Critical Review: Glacier Bancorp (NYSE:GBCI) versus Hope Bancorp (NASDAQ:HOPE)

Glacier Bancorp (NYSE: GBCI - Get Free Report) and Hope Bancorp (NASDAQ: HOPE - Get Free Report) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations. Dividends Glacier Bancorp pays an annual dividend of

Feb 01, 2026 09:02 PM defenseworld.net

Price Targets